Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy
- 1 February 1991
- journal article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 83 (1-2) , 43-53
- https://doi.org/10.1007/bf01244451
Abstract
The administration of the 5-HT1A agonist 8-OH-DPAT, 0.1 mg kg−1 sc −20 min, produced a moderate suppression of conditioned avoidance behavior (60% of controls) in the rat. This effect, however, was not seen after administration of higher doses, 0.4 and 1.6 mg kg−1 sc. The number of intertriai crosses were not affected by the lower dose but significantly increased by administration of the two higher doses of 8-OH-DPAT. The dopamine D2 receptor blocking agent raclopride, 0.05 mg kg−1, by itself did not suppress the avoidance behavior, but in combination with 8-OH-DPAT produced suppression of avoidance behavior (30% of controls) as well as intertrial crosses. Open field locomotor activity was suppressed by raclopride, 0.1 mg kg−1 sc, or by 8-OH-DPAT, 0.1 mg kg−1 sc. The combined treatment produced a further suppression of locomotor activity and a marked increase in “immobility” (stationary movements). Treadmill locomotion, however, was not affected by either compound by itself, whereas the combined treatment impaired treadmill performance. Suppression of treadmill performance by a higher dose of raclopride, 0.4 mg kg−1 sc, was not altered by the additional treatment with 8-OH-DPAT, 0.1 mg kg−1. In contrast to the additive effects of 8-OH-DPAT and raclopride on conditioned avoidance behavior, open field locomotion and treadmill performance, the catalepsy produced by raclopride, 16 mg kg−1 was completely antagonised by treatment with 8-OH-DPAT 0.1 mg kg−1. Taken together, the present findings demonstrate strong interactions between a 5-HT agonist and a DA D2 antagonist on some critical tests for antipsychotic-like actions and extrapyramidal motor effects in rats, and suggest new possibilities in the search for new antipsychotic drugs with higher clinical efficacy and less extrapyramidal side effectsKeywords
This publication has 27 references indexed in Scilit:
- Effects of 5-HT and 8-OH-DPAT on forebrain monoamine synthesis after local application into the median and dorsal raphe nuclei of the ratJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1990
- Effects of 8-OH-DPAT on motor activity in the ratPharmacology Biochemistry and Behavior, 1989
- Reversal of neuroleptic-induced catalepsy by novel aryl-piperazine anxiolytic drugsJournal of Pharmacy and Pharmacology, 1988
- Suppression of conditioned avoidance by 8-OH-DPAT in the ratJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
- Effects of Raclopride on Exploratory Locomotor Activity, Treadmill Locomotion, Conditioned Avoidance Behaviour and Catalepsy in Rats: Behavioural Profile Comparisons between Raclopride, Haloperidol and PreclamolBasic & Clinical Pharmacology & Toxicology, 1987
- Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: A comparison between the effects produced by pre- and post-synaptic inhibition of dopaminergic neurotransmissionPharmacology Biochemistry and Behavior, 1986
- A Central Serotonin Receptor Agonist, 8‐Hydroxy‐2‐(di‐n‐propylamino)tetralin, has Different Effects on Prolactin Secretion in Male and Female RatsActa Pharmacologica et Toxicologica, 1986
- Comparative chronic effects of buspirone or neuroleptics on rat brain dopaminergic neurotransmissionJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- 8-hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activityJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1982
- Role of 5-HT in the Action of Some Drugs Affecting Extrapyramidal SystemPharmacology, 1973